Savara Inc —— 季度财务数据 (NASDAQ:SVRA)

Financials

经营活动产生的现金 -23.28 M-27.19 M-26.26 M-22.53 M-25.06 M -101.04 M 投资活动产生的现金 17.89 M29.33 M24.33 M21.47 M-93.56 M -18.44 M 融资活动产生的现金 -843 K2.32 M-49 K-23 K135.56 M 137.81 M 自由现金流 -23.27 M-27.19 M-26.28 M-22.53 M-25.06 M -101.06 M

新闻

H.C. Wainwright重申Savara股票评级,目标价10美元

H.C. Wainwright reiterates Savara stock rating, $10 target

Savara获FDA优先审评罕见肺病药物有望获批

Savara receives FDA priority review for rare lung disease drug

Savara获FDA第74天函,自身免疫性PAP药物无需召开咨询委员会会议

Savara receives FDA day 74 letter for autoimmune PAP drug

Hercules Capital COO Follmann buys $73,400 in HTGC stock

Hercules Capital COO Follmann buys $73,400 in stock

Hercules Capital首席财务官Meyer买入20万美元HTGC股票

Hercules Capital董事Badavas买入7.5万美元股票

Hercules Capital董事Fallon买入价值14.98万美元股票

Hercules Capital director Fallon buys $149,800 in shares